Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stella Forte (Стелла Форте) is a dietary supplement developed and manufactured by the Russian company Diod (Завод экологической техники и экопитания «ДИОД»). It is positioned as an ophthalmology-focused supplement intended to support eye health and manage various ophthalmologic conditions. As a 'Biologically Active Supplement' (БАД) under Russian regulatory standards, it is explicitly classified as a non-medicinal product. The supplement is part of Diod's broader portfolio of health-supporting products, which includes other well-known brands such as Kapilar and Okulist. Stella Forte is typically administered orally, often in capsule form, to provide nutritional support for visual function, although its specific molecular mechanism of action and detailed ingredient profile for the ophthalmology-specific version are not extensively documented in pharmaceutical clinical trial databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Stella Forte.